Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383486 · ClinicalTrials.gov registry record · Phase 3
Self Selection Trial of Naproxen Sodium
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 253
- Enrollment target
NCT01383486 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 253 participants.
The verdict
NCT01383486, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 253 participants
- Enrollment target
Study Summary
A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.
Interventions
- DRUG Naproxen sodium ER (BAYH6689)
- DRUG Advil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01383486
The ClinicalTrials.gov registry entry for NCT01383486 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naproxen sodium ER (BAYH6689) is the first listed.
NCT01383486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01383486 about?
NCT01383486 is a clinical study titled "Self Selection Trial of Naproxen Sodium". A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.
What is the current status of trial NCT01383486?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 253 participants. The study started on 2011-07. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01383486?
The interventions under investigation include: Naproxen sodium ER (BAYH6689) (DRUG), Advil (DRUG).
Who is sponsoring clinical trial NCT01383486?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.